Metabolic Disease Services Platform
Metabolic diseases are considered to arise from multiple factors (such as genetics, diet, age, and environmental factors) and often affect various organs throughout the body. No single cause is solely responsible for these disorders.
To support research in this area, WuXi AppTec offers a comprehensive platform of in vitro and in vivo services. Our capabilities include a well-established panel of validated and clinically relevant animal models as well as advanced technologies to study obesity, diabetes, hyperlipidemia, and rare metabolic diseases.
Flyer_Metabolic Disease Platform
Related Content
Glucagon‐like peptide‐1 (GLP-1) receptor agonists have emerged as promising therapeutic options for addressing type‐2 diabetes, obesity, and related conditions. However,...
VIEW RESOURCECasein kinase 2-interacting protein-1 (CKIP-1) performs a critical negative role in the regulation of bone formation. Accumulated evidence strongly supports...
VIEW RESOURCE